text
stringlengths 15
247
|
|---|
Lung, biopsy;
Squamous cell carcinoma
|
Stomach, endoscopic biopsy;
Adenocarcinoma, well differentiated
|
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 6 (3+3), grade group 1, tumor volume: 10%
|
Prostate, biopsy;
No tumor present
|
Stomach, endoscopic biopsy;
Chronic active gastritis
with 1) ulcer
2) interstinal metaplasia
|
Stomach, endoscopic biopsy;
Tubular adenoma with low grade dysplasia
|
Stomach, endoscopic biopsy;
Tubular adenoma with low grade dysplasia
|
Stomach, endoscopic biopsy;
Tubular adenoma with low grade dysplasia
|
Stomach, endoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Stomach, endoscopic biopsy;
Tubular adenoma with low grade dysplasia
|
Lung, biopsy;
Adenocarcinoma
|
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 7 (4+3), grade group 3 (Gleason pattern 4: 80%), tumor volume: 50%
|
Colon, colonoscopic biopsy;
Adenocarcinoma, well differentiated
|
Prostate, biopsy;
No tumor present
|
Stomach, endoscopic biopsy;
Tubular adenoma with low grade dysplasia
|
Stomach, endoscopic biopsy;
Adenocarcinoma, poorly differentiated
|
Lung, biopsy;
No evidence of malignancy or granuloma
|
Lung, biopsy;
1. No evidence of malignancy or granuloma
2. Chronic inflammation with organizing fibrosis
|
Prostate, biopsy;
No tumor present
|
Prostate, biopsy;
No tumor present
|
Stomach, endoscopic biopsy;
Tubular adenoma with low grade dysplasia
|
Stomach, endoscopic biopsy;
Tubular adenoma with low grade dysplasia
|
Stomach, endoscopic biopsy;
Tubular adenoma with low grade dysplasia
|
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 6 (3+3), grade group 1, tumor volume: 30%
|
Stomach, endoscopic biopsy;
Adenocarcinoma, well differentiated
|
Stomach, endoscopic biopsy;
Tubular adenoma with low grade dysplasia
|
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 8 (4+4), grade group 4, tumor volume: 100%
|
Stomach, endoscopic biopsy;
Chronic active gastritis
|
Stomach, endoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Lung, biopsy;
Squamous cell carcinoma
|
Stomach, endoscopic biopsy;
Chronic gastritis
|
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 6 (3+3), grade group 1, tumor volume: 30%
|
Stomach, endoscopic biopsy;
Tubular adenoma with low grade dysplasia
|
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 6 (3+3), grade group 1, tumor volume: 25%
|
Prostate, biopsy;
No tumor present
|
Stomach, endoscopic biopsy;
Chronic active gastritis
with interstinal metaplasia
|
Prostate, biopsy;
No tumor present
|
Stomach, endoscopic biopsy;
Chronic gastritis
with interstinal metaplasia
|
Stomach, endoscopic biopsy;
Tubular adenoma with low grade dysplasia
|
Stomach, endoscopic biopsy;
Chronic active gastritis
with interstinal metaplasia
|
Lung, biopsy;
Adenocarcinoma
|
Lung, biopsy;
Adenocarcinoma
|
Lung, biopsy;
1. No evidence of malignancy or granuloma
2. Chronic inflammation with organizing fibrosis
|
Stomach, endoscopic biopsy;
Chronic active gastritis
|
Lung, biopsy;
Adenocarcinoma
|
Lung, biopsy;
Small cell carcinoma
|
Stomach, endoscopic biopsy;
Tubular adenoma with low grade dysplasia
|
Lung, biopsy;
No evidence of malignancy or granuloma
|
Lung, biopsy;
Squamous cell carcinoma
|
Lung, biopsy;
Non-small cell carcinoma, favor adenocarcinoma
|
Lung, biopsy;
Non-small cell carcinoma, favor squamous cell carcinoma
|
Stomach, endoscopic biopsy;
Tubular adenoma with low grade dysplasia
|
Stomach, endoscopic biopsy;
Adenocarcinoma, well differentiated
|
Stomach, endoscopic biopsy;
Tubular adenoma with low grade dysplasia
|
Lung, biopsy;
No evidence of malignancy or granuloma
|
Colon, colonoscopic biopsy;
Chronic nonspecific inflammation
|
Lung, biopsy;
Adenocarcinoma
|
Stomach, endoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Stomach, endoscopic biopsy;
Adenocarcinoma, poorly differentiated with poorly cohesive carcinoma component
|
Lung, biopsy;
Adenocarcinoma
|
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 8 (4+4), grade group 4, tumor volume: 5%
|
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 7 (3+4), grade group 2 (Gleason pattern 4: 30%), tumor volume: 10%
|
Lung, biopsy;
Squamous cell carcinoma
|
Lung, biopsy;
Chronic granulomatous inflammation with necrosis
|
Lung, biopsy;
Squamous cell carcinoma
|
Stomach, endoscopic biopsy;
Chronic gastritis
with erosion
|
Stomach, endoscopic biopsy;
Extranodal marginal zone B cell lymphoma of MALT type
|
Stomach, endoscopic biopsy;
Tubular adenoma with low grade dysplasia
|
Stomach, endoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Stomach, endoscopic biopsy;
Tubular adenoma with low grade dysplasia
|
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 7 (4+3), grade group 3 (Gleason pattern 4: 70%), tumor volume: 90%
|
Stomach, endoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Stomach, endoscopic biopsy;
Adenocarcinoma, well differentiated
|
Lung, biopsy;
Metastatic adenocarcinoma, from colon primary
|
Colon, colonoscopic biopsy;
Chronic active colitis
|
Lung, biopsy;
Adenocarcinoma
|
Stomach, endoscopic biopsy;
Chronic active gastritis
with interstinal metaplasia
|
Lung, biopsy;
Squamous cell carcinoma
|
Lung, biopsy;
Adenocarcinoma
|
Lung, biopsy;
Adenocarcinoma
|
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 7 (4+3), grade group 2 (Gleason pattern 4: 70%), tumor volume: 90%
|
Stomach, endoscopic biopsy;
Tubular adenoma with low grade dysplasia
|
Lung, biopsy;
Adenocarcinoma
|
Stomach, endoscopic biopsy;
Adenocarcinoma, well differentiated
|
Stomach, endoscopic biopsy;
Tubular adenoma with low grade dysplasia
|
Colon, colonoscopic biopsy;
Chronic nonspecific inflammation
|
Stomach, endoscopic biopsy;
Chronic gastritis
with interstinal metaplasia
|
Stomach, endoscopic biopsy;
Hyperplastic polyp
|
Stomach, endoscopic biopsy;
Tubular adenoma with low grade dysplasia
|
Lung, biopsy;
Squamous cell carcinoma
|
Stomach, endoscopic biopsy;
Tubular adenoma with low grade dysplasia
|
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 7 (4+3), grade group 3 (Gleason pattern 4: 80%), tumor volume: 70%
|
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 8 (4+4), grade group 4, tumor volume: 100%
|
Stomach, endoscopic biopsy;
Chronic gastritis
|
Lung, biopsy;
Small cell carcinoma
|
Prostate, biopsy;
Malignant lymphoma
|
Stomach, endoscopic biopsy;
Adenocarcinoma, well differentiated
|
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 6 (3+3), grade group 1, tumor volume: 10%
|
Lung, biopsy;
No evidence of malignancy or granuloma
|
Stomach, endoscopic biopsy;
Extranodal marginal zone B cell lymphoma of MALT type
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.